Novo Nordisk has moved quickly to file for approval of a new, higher-dose version of its obesity therapy Wegovy as it tries to fend off a growing challenge in the market from arch-rival Eli Lilly.

Having bloodwork done is like getting the inside scoop on your health. But if your panel comes back with something outside the normal range, like high estrogen, it’s understandable if you have some ...